Contribution of inflammatory processes to Alzheimer's disease: Molecular mechanisms

International Journal of Developmental Neuroscience

Volumn 24, Issue 2-3, 2006, Pages 167-176

  Sastre, Magdalena ^a   Klockgether, Thomas ^a   Heneka, Michael T ^b  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Alzheimer's disease; BACE; Inflammation; NSAIDs; PPAR

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACETYLSALICYLIC ACID; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; CELL NUCLEUS RECEPTOR; CHEMOKINE; CYTOKINE; FLURBIPROFEN; IBUPROFEN; INDOMETACIN; LIGAND; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ANTAGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIOGLITAZONE; PROSTAGLANDIN J2; ROSIGLITAZONE; SULINDAC SULFIDE; TROGLITAZONE;

ALZHEIMER DISEASE; ANTIINFLAMMATORY ACTIVITY; ASTROCYTE; CELL CULTURE; CELL DEATH; CONFERENCE PAPER; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; HUMAN; INFLAMMATION; MICROGLIA; MOLECULAR MECHANICS; NERVE CELL DEGENERATION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN METABOLISM; RISK FACTOR;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASTROCYTES; CHEMOKINES; CYTOKINES; ENCEPHALITIS; HUMANS; MICROGLIA; MODELS, BIOLOGICAL; TRANSCRIPTION FACTORS;

ANIMALIA;

EID: 33644516288     PISSN: 07365748     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijdevneu.2005.11.014     Document Type: Conference Paper

References (122)

1. E.D. Agdeppa, V. Kepe, A. Petri, N. Satyamurthy, J. Liu, S.C. Huang, G.W. Small, G.M. Cole, and J.R. Barrio In vitro detection of (S)-naproxen and ibuprofen binding to plaques in the Alzheimer's brain using the positron emission tomography molecular imaging probe 2-(1-[6-[(2-[(18)F]fluoroethyl) (methyl)amino]-2-naphthyl]ethylidene)malononitrile Neuroscience 117 2003 723 730
2. P.S. Aisen Inflammation and Alzheimer's disease: mechanisms and therapeutic strategies Gerontology 43 1997 143 149
3. P.S. Aisen, K.A. Schafer, M. Grundman, E. Pfeiffer, M. Sano, K.L. Davis, M.R. Farlow, S. Jin, R.G. Thomas, L.J. Thal Alzheimer's Disease Cooperative Study Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial JAMA 289 2003 2819 2826
4. H. Akiyama, S. Barger, S. Barnum, B. Bradt, J. Bauer, G.M. Cole, N.R. Cooper, P. Eikelenboom, M. Emmerling, B.L. Fiebich, C.E. Finch, S. Frautschy, W.S.T. Griffin, H. Hampel, M. Hull, G. Landreth, L.-F. Lue, R. Mrak, and I.R. Mackenzie Inflammation and Alzheimer's disease Neurobiol. Aging 21 2000 383 421
5. I. Alafuzoff, M. Overmyer, S. Helisalmi, and H. Soininen Lower counts of astroglia and activated microglia in patients with Alzheimer's Disease with regular use of non-steroidal anti-inflammatory drugs J. Alzheimers Dis. 2 2000 37 46
6. D. Altshuler, J.N. Hirschhorn, M. Klannemark, C.M. Lindgren, M.C. Vohl, J. Nemesh, C.R. Lane, S.F. Schaffner, S. Bolk, C. Brewer, T. Tuomi, D. Gaudet, T.J. Hudson, M. Daly, L. Groop, and E.S. Lander The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes Nat. Genet. 26 2000 76 80
7. F.M. Amara, A. Junaid, R.R. Clough, and B. Liang TGF-β(1), regulation of alzheimer amyloid precursor protein mRNA expression in a normal human astrocyte cell line: mRNA stabilization Brain Res. Mol. Brain Re. 71 1999 42 49
8. J. Apelt, and R. Schliebs β-amyloid-induced glial expression of both pro- and anti-inflammatory cytokines in cerebral cortex of aged transgenic Tg2576 mice with Alzheimer plaque pathology Brain Res. 894 2001 21 30
9. Y. Avramovich, T. Amit, and M.B. Youdim Non-steroidal anti-inflammatory drugs stimulate secretion of non-amyloidogenic precursor protein J. Biol. Chem. 277 2002 31273 31466
10. J.H. Bach, H.S. Chae, J.C. Rah, M.W. Lee, C.H. Park, S.H. Choi, J.K. Choi, S.H. Lee, Y.S. Kim, K.Y. Kim, W.B. Lee, Y.H. Suh, and S.S. Kim C-terminal fragment of amyloid precursor protein induces astrocytosis J. Neurochem. 78 2001 109 120
11. Y. Barak, M.C. Nelson, E.S. Ong, Y.Z. Jones, P. Ruiz-Lozano, K.R. Chien, A. Koder, and R.M. Evans PPARγ is required for placental, cardiac, and adipose tissue development Mol. Cell. 4 1999 585 595
12. F. Bard, C. Cannon, R. Barbour, R.L. Burke, D. Games, H. Grajeda, T. Guido, K. Hu, J. Huang, K. Johnson-Wood, K. Khan, D. Kholodenko, M. Lee, I. Lieberburg, R. Motter, M. Nguyen, F. Soriano, N. Vasquez, K. Weiss, B. Welch, P. Seubert, D. Schenk, and T. Yednock Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease Nat. Med. 6 2000 916 919
13. S.W. Barger, and A.D. Harmon Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E Nature 388 1997 878 881
14. V. Beglopoulos, X. Sun, C.A. Saura, C.A. Lemere, R.D. Kim, and J. Shen Reduced β-amyloid production and increased inflammatory responses in presenilin conditional knock-out mice J. Biol. Chem. 279 2004 46907 46914
15. A. Bellucci, A.J. Westwood, E. Ingram, F. Casamenti, M. Goedert, and M.G. Spillantini Induction of inflammatory mediators and microglial activation in mice transgenic for mutant human P301S tau protein Am. J. Pathol. 165 2004 1643 1652
16. W.C. Benzing, J.R. Wujek, E.K. Ward, D. Shaffer, K.H. Ashe, S.G. Younkin, and K.R. Brunden Evidence for glial-mediated inflammation in aged APPSw transgenic mice Neurobiol. Aging 16 2000 523 530
17. I. Blasko, A. Apochal, G. Boeck, T. Hartmann, B. Grubeck-Loebenstein, and G. Ransmayr Ibuprofen decreases cytokine-induced amyloid β production in neuronal cells Neurobiol. Dis. 8 2001 1094 1101
18. I. Blasko, R. Beer, M. Bigl, J. Apelt, G. Franz, D. Rudzki, G. Ransmayr, A. Kampfl, and R. Schliebs Experimental traumatic brain injury in rats stimulates the expression, production and activity of Alzheimer's disease β-secretase (BACE-1) J. Neural Transm. 111 2004 523 536
19. T. Breidert, J. Callebert, M.T. Heneka, G. Landreth, J.M. Launay, and E.C. Hirsch Protective action of the peroxisome proliferator-activated receptor-gamma agonist pioglitazone in a mouse model of Parkinson's disease J. Neurochem. 82 2002 615 624
20. J.C. Breitner, and P.P. Zandi Do nonsteroidal antiinflammatory drugs reduce the risk of Alzheimer's disease? N. Engl. J. Med. 345 2001 1567 1568
21. S. Brune, H. Kolsch, U. Ptok, M. Majores, A. Schulz, R. Schlosser, M.L. Rao, W. Maier, and R. Heun Polymorphism in the peroxisome proliferator-activated receptor-α gene influences the risk for Alzheimer's disease J. Neural Transm. 110 2003 1041 1050
22. A.L. Brunkan, and A.M. Goate Presenilin function and γ-secretase activity J. Neurochem. 3 2005 769 792
23. A. Cagnin, D.J. Brooks, A.M. Kennedy, R.N. Gunn, R. Myers, F.E. Turkheimer, T. Jones, and R.B. Banati In-vivo measurement of activated microglia in dementia Lancet 358 2001 461 567
24. I.E. Camacho, L. Serneels, K. Spittaels, P. Merchiers, D. Dominguez, and B. De Strooper Peroxisome proliferator-activated receptor-γ induces a clearance mechanism for the amyloid-β peptide J. Neurosci. 24 2004 10908 10917
25. C.K. Combs, D.E. Johnson, J.C. Karlo, S.B. Cannady, and G.E. Landreth Inflammatory mechanisms in Alzheimer's disease: inhibition of β-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARγ agonists J. Neurosci. 20 2000 558 567
26. C.K. Combs, J.C. Karlo, S.C. Kao, and G.E. Landreth β-Amyloid stimulation of microglia and monocytes results in TNFα-dependent expression of inducible nitric oxide synthase and neuronal apoptosis J. Neurosci. 21 2001 1179 1188
27. R. Cunard, M. Ricote, D. DiCampli, D.C. Archer, D.A. Kahn, C.K. Glass, and C.J. Kelly Regulation of cytokine expression by ligands of peroxisome proliferator activated receptors J. Immunol. 168 2002 2795 2802
28. C. d'Abramo, S. Massone, J.M. Zingg, A. Pizzuti, P. Marambaud, B. Dalla Piccola, A. Azzi, U.M. Marinari, M.A. Pronzato, and R. Ricciarelli Role of peroxisome proliferator-activated receptor gamma in amyloid precursor protein processing and amyloid beta-mediated cell death Biochem. J. 391 2005 693 698
29. M.R. D'Andrea, G.M. Cole, and M.D. Ard The microglial phagocytic role with specific plaque types in the Alzheimer disease brain Neurobiol. Aging 25 2004 675 683
30. R.A. Daynes, and D.C. Jones Emerging roles of PPARs in inflammation and immunity Nat. Rev. Immunol. 2 2002 748 759
31. M. Deckert, G. Reifenberger, U.-N. Riede, W. Schlote, D.R. Thal, and O.D. Wiestler In nervensystem U.-N. Riede M. Werner H.-E. Schäfer Allgemeine und Spezielle Pathologie vol. 5 2004 Thieme Stuggart 1039 1114
32. L.A. DeGiorgio, Y. Shimizu, H.S. Chun, Y.S. Kim, S. Sugama, J.H. Son, T.H. Joh, and B.T. Volpe Amyloid precursor protein gene disruption attenuates degeneration of substantia nigra compacta neurons following axotomy Brain Res. 938 2002 38 44
33. T. Dehmer, M.T. Heneka, M. Sastre, J. Dichgans, and J.B. Schulz Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with I kappa B alpha induction and block of NF kappa B and iNOS activation J. Neurochem. 88 2004 494 501
34. A. Diab, C. Deng, J.D. Smith, R.Z. Hussain, B. Phanavanh, A.E. Lovett-Racke, P.D. Drew, and M.K. Racke Peroxisome proliferator-activated receptor-gamma agonist 15-deoxy-Delta(12,14)-prostaglandin J(2) ameliorates experimental autoimmune encephalomyelitis J. Immunol. 168 2002 2508 2515
35. D.W. Dickson, S.C. Lee, L.A. Mattiace, S.H. Yen, and C. Brosnan Microglia and cytokines in neurological disease, with special reference to AIDs and Alzheimer's disease Glia 7 1993 75 83
36. J.L. Eriksen, S.A. Sagi, T.E. Smith, S. Weggen, P. Das, D.C. McLendon, V.V. Ozols, K.W. Jessing, K.H. Zavitz, E.H. Koo, and T.E. Golde NSAIDs and enantiomers of flurbiprofen target γ-secretase and lower Aβ 42 in vivo J. Clin. Invest. 112 2003 440 449
37. M. Etminan, S. Gill, and A. Samii Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: systematic review and meta-analysis of observational studies BMJ 327 2003 128
38. D.L. Feinstein, E. Galea, V. Gavrilyuk, C.F. Brosnan, C.C. Whitacre, L. Dumitrescu-Ozimek, G.E. Landreth, H.A. Pershadsingh, G. Weinberg, and M.T. Heneka Peroxisome proliferator-activated receptor-gamma agonists prevent experimental autoimmune encephalomyelitis Ann. Neurol. 51 2002 694 702
39. L. Fetler, and S. Amigorena Neuroscience. Brain under surveillance: the microglia patrol Science 309 2005 392 393
40. S.A. Frautschy, F. Yang, M. Irrizarry, B. Hyman, T.C. Saido, K. Hsiao, and G.M. Cole Microglial response to amyloid plaques in APPsw transgenic mice Am. J. Pathol. 152 1998 307 317
41. D. Frenkel, R. Maron, D.S. Burt, and H.L. Weiner Nasal vaccination with a proteosome-based adjuvant and glatiramer acetate clears β-amyloid in a mouse model of Alzheimer disease J. Clin. Invest. 115 2005 2423 2433
42. D. Games, D. Adams, R. Alessandrini, R. Barbour, P. Berthelette, C. Blackwell, T. Carr, J. Clemens, T. Donaldson, F. Gillespie, T. Duido, S. Hagopian, K. Johnson-Wood, K. Khan, M. Lee, P. Leibowitz, S. Little, E. Masliah, L. McConlogue, M. Montoya-Zavala, L. Mucke, L. Paganini, E. Penniman, M. Power, D. Schenk, P. Seubert, B. Snyder, F. Soriano, H. Tan, J. Vitale, S. Wadsworth, B. Wolozin, and J. Zhao Alzheimer-type neuropathology in transgenic mice overexpressing V717F-amyloid precursor protein Nature 373 1995 523 527
43. D.S. Gelinas, K. DaSilva, D. Fenili, P. St George-Hyslop, and J. McLaurin Immunotherapy for Alzheimer's disease Proc. Natl. Acad. Sci. U.S.A. 101 Suppl. 2 2004 14657 14662
44. J.M. Gimble, C.E. Robinson, X. Wu, K.A. Kelly, B.R. Rodriguez, S.A. Kliewer, J.M. Lehmann, and D.C. Morris Peroxisome proliferator-activated receptor-γ activation by thiazolidinediones induces adipogenesis in bone marrow stromal cells Mol. Pharmacol. 50 1996 1087 1094
45. W.S. Griffin, J.G. Sheng, and M.C. Royston Glial-neuronal interactions in Alzheimer's disease: the potential role of a 'cytokine cycle' in disease progression Brain Pathol. 8 1998 65 72
46. J.T. Guo, J. Yu, D. Grass, F.C. de Beer, and M.S. Kindy Inflammation-dependent cerebral deposition of serum amyloid a protein in a mouse model of amyloidosis J. Neurosci. 22 2002 5900 5909
47. M. Hartlage-Rubsamen, U. Zeitschel, J. Apelt, U. Gartner, H. Franke, T. Stahl, A. Gunther, R. Schliebs, M. Penkowa, V. Bigl, and S. Rossner Astrocytic expression of the Alzheimer's disease β-secretase (BACE1) is stimulus-dependent Glia 4 2003 169 179
48. S. Hauser, G. Adelmant, P. Sarraf, H.M. Wright, E. Mueller, and B.M. Spiegelman Degradation of the peroxisome proliferator-activated receptorγ is linked to ligand-dependent activation J. Biol. Chem. 275 2000 18527 18533
49. M.T. Heneka, H. Wiesinger, L. Dumitrescu-Ozimek, P. Riederer, D.L. Feinstein, and T. Klockgether Neuronal and glial coexpression of argininosuccinate synthetase and inducible nitric oxide synthase in Alzheimer disease J. Neuropathol. Exp. Neurol. 60 2001 906 916
50. M.T. Heneka, M. Sastre, L. Dumitrescu-Ozimek, I. Dewachter, J. Walter, T. Klockgether, and F. Van Leuven Focal glial activation coincides with increased BACE1 activation and precedes amyloid plaque deposition in APP[V717I] transgenic mice J. Neuroinflamm. 2 2005 22 33
51. M.T. Heneka, M. Sastre, L. Dumitrescu-Ozimek, A. Hanke, I. Dewachter, C. Kuiperi, K. O'banion, T. Klockgether, F. Van Leuven, and G.E. Landreth Acute treatment with the PPARγ agonist pioglitazone and ibuprofen reduces glial inflammation and Aβ1-42 levels in APPV717I transgenic mice Brain 128 2005 1442 1453
52. G.J. Ho, R. Drego, E. Hakimian, and E. Masliah Mechanisms of cell signaling and inflammation in Alzheimer's disease Curr. Drug Targets Inflamm. Allergy 4 2005 247 256
53. B.A. In't Veld, A. Ruitenberg, A. Hofman, L.J. Launer, C.M. van Duijn, T. Stijnen, M.M.B. Breteler, and B.H.C. Stricker Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease N. Engl. J. Med. 345 2001 1515 1521
54. C. Jiang, A.T. Ting, and B. Seed PPAR-γ agonists inhibit production of monocyte inflammatory cytokines Nature 391 1998 82 86
55. M.I. Kamboh, D.K. Sanghera, R.E. Ferrell, and S.T. DeKosky APOE*4-associated Alzheimer's disease risk is modified by α 1-antichymotrypsin polymorphism Nat. Genet. 10 1995 486 488
56. Y. Kitamura, S. Shimohama, H. Koike, J. Kakimura, Y. Matsuoka, Y. Nomura, P.J. Gebicke-Haerter, and T. Taniguchi Increased expression of cyclooxygenases and peroxisome proliferator-activated receptor-gamma in Alzheimer's disease brains Biochem. Biophys. Res. Commun. 254 1999 582 586
57. S.A. Kliewer, B.M. Forman, B. Blumberg, E.S. Ong, U. Borgmeyer, D.J. Mangelsdorf, K. Umesono, and R.M. Evans Differential expression and activation of a family of murine peroxisome proliferator-activated receptors Proc. Natl. Acad. Sci. U.S.A. 91 1994 7355 7359
58. L. Klotz, S. Schmidt, M. Schmidt, M. Sastre, T. Klockgether, and M.T. Heneka Anti-inflammatory and antiproliferative actions of peroxisome proliferator-activated receptor-γ (PPARγ) agonists on T-lymphocytes in multiple sclerosis patients and healthy controls Mediators Inflamm. 13 2004 61
59. G.W. Kreutzberg Microglia: a sensor for pathological events in the CNS Trends Neurosci. 19 1996 312 318
60. M. Kudo, A. Sugawara, A. Uruno, K. Takeuchi, and S. Ito Transcription suppression of peroxisome proliferator-activated receptor-γ2 gene expression by tumor necrosis factor-α via an inhibition of CCAAT/ enhancer-binding protein delta during the early stage of adipocyte differentiation Endocrinology 145 2004 4948 4956
61. T. Kukar, M.P. Murphy, J.L. Eriksen, S.A. Sagi, S. Weggen, T.E. Smith, T. Ladd, M.A. Khan, R. Kache, J. Beard, M. Dodson, S. Merit, V.V. Ozols, P.Z. Anastasiadis, P. Das, A. Fauq, E.H. Koo, and T.E. Golde Diverse compounds mimic Alzheimer disease-causing mutations by augmenting Aβ42 production Nat. Med. 11 2005 545 550
62. G.E. Landreth, and M.T. Heneka Anti-inflammatory actions of peroxisome proliferator-activated receptor-γ agonists in Alzheimer's disease Neurobiol. Aging 22 2001 937 944
63. J.M. Lehmann, J.M. Lenhard, B.B. Oliver, G.M. Ringold, and S.A. Kliewer Peroxisome proliferator-activated receptors α and γ are activated by indomethacin and other non-steroidal anti-inflammatory drugs J. Biol. Chem. 272 1997 3406 3410
64. A.C. Li, and C.K. Glass PPAR- and LXR-dependent pathways controlling lipid metabolism and the development of atherosclerosis J. Lipid Res. 45 2004 2161 2173
65. A.C. Li, K.K. Brown, M.J. Silvestre, T.M. Willson, W. Palinski, and C.K. Glass Peroxisome proliferator-activated receptorγ ligands inhibit development of atherosclerosis in LDL receptor-deficient mice J. Clin. Invest. 106 2000 523 531
66. G.P. Lim, F. Yang, T. Chu, P. Chen, W. Beech, B. Teter, T. Tran, O. Ubeda, K.H. Ashe, S.A. Frautschy, and G.M. Cole Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease J. Neurosci. 20 2000 5709 5714
67. G.P. Lim, F. Yang, T. Chu, E. Gahtan, O. Ubeda, W. Beech, J.B. Overmier, K. Hsiao-Ashec, S.A. Frautschy, and G.M. Cole Ibuprofen effects on Alzheimer pathology and open field activity in APPsw transgenic mice Neurobiol. Aging 22 2001 983 991
68. B. Liu, and J.-S. Hong Role of Microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention JPET 304 2003 1 7
69. A. Lleo, O. Berezovska, L. Herl, S. Raju, A. Deng, B.J. Bacskai, M.P. Frosch, M. Irizarry, and B.T. Hyman Nonsteroidal anti-inflammatory drugs lower Aβ42 and change presenilin 1 conformation Nat. Med. 10 2004 1065 1066
70. D. Lütjohann, O. Breuer, G. Ahlborg, I. Nennesmo, A. Siden, U. Dicfalusy, and I. Björkhem Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24Shydroxycholesterol from the brain into the circulation Proc. Natl. Acad. Sci. U.S.A. 93 1996 9799 9804
71. D. Lütjohann, A. Papassotiropoulos, I. Björkhem, S. Locatelli, M. Bagli, R.D. Oehring, U. Schlegel, F. Jessen, M.L. Rao, K. von Bergmann, and R. Heun Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients J. Lipid Res. 41 2000 195 198
72. I.R. Mackenzie, and D.G. Munoz Nonsteroidal anti-inflammatory drug use and Alzheimer-type pathology in aging Neurology 50 1998 986 990
73. Y. Matsuoka, M. Picciano, B. Malester, J. LaFrancois, C. Zehr, J.M. Daeschner, J.A. Olschowka, M.I. Fonseca, M.K. O'Banion, A.J. Tenner, C.A. Lemer, and K. Duff Inflammatory responses to amyloidosis in a transgenic mouse model of Alzheimer's disease Am. J. Pathol. 158 2001 1345 1354
74. S.M. McCusker, M.D. Curran, K.B. Dynan, C.D. McCullagh, D.D. Urquhart, D. Middleton, C.C. Patterson, S.P. Mcllroy, and A.P. Passmore Association between polymorphism in regulatory region of gene encoding TNFα and risk of Alzheimer disease and vascular dementia: a case-control study Lancet 357 2001 436 439
75. P.L. McGeer, T. Kawamata, D.G. Walker, H. Akiyama, I. Tooyama, and E.G. McGeer Microglia in degenerative neurological disease Glia 7 1993 84 92
76. P.L. McGeer, M. Schulzer, and E.G. McGeer Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies Neurology 47 1996 425 432
77. S. Moreno, S. Farioli-Vecchioli, and M.P. Ceru Immunolocalization of peroxisome proliferator-activated receptors and retinoid X receptors in the adult rat CNS Neuroscience 123 2004 131 145
78. T. Morihara, B. Teter, F. Yang, G.P. Lim, S. Boudinot, F.D. Boudinot, S.A. Frautschy, and G.M. Cole Ibuprofen suppresses interleukin-1β induction of pro-amyloidogenic alpha1-antichymotrypsin to ameliorate β-amyloid (Aβ) pathology in Alzheimer's models Neuropsychopharmacology 30 2005 1111 1120
79. R.G. Nagele, M.R. D'Andrea, H. Lee, V. Venkataraman, and H.Y. Wang Astrocytes accumulate Aβ42 and give rise to astrocytic amyloid plaques in Alzheimer disease brains Brain Res. 971 2003 197 209
80. J.A. Nicoll, R.E. Mrak, D.I. Graham, J. Steward, G. Wilcock, S. MacGowan, M.M. Esiri, L.S. Murray, D. Dewar, S. Love, T. Moss, and W.S. Griffin Association of interleukin-1 gene polymorphisms with Alzheimer's disease Ann. Neurol. 47 2000 365 368
81. M. Niino, K. Iwabuchi, S. Kikuchi, M. Ato, T. Morohashi, A. Ogata, K. Tashiro, and K. Onoe Amelioration of experimental autoimmune encephalomyelitis in C57BL/6 mice by an agonist of peroxisome proliferator-activated receptor-gamma J. Neuroimmunol. 116 2001 40 48
82. A. Nunomura, G. Perry, G. Aliev, K. Hirai, A. Takeda, E.K. Balraj, P.K. Jones, H. Ghanbari, T. Wataya, S. Shimohama, S. Chiba, C.S. Atwood, R.B. Petersen, and M.A. Smith Oxidative damage is the earliest event in Alzheimer disease J. Neuropathol. Exp. Neurol. 60 2001 759 767
83. A.M. Palmer Neurochemical studies of Alzheimer's disease Neurodegeneration 5 1996 381 391
84. A. Papassotiropoulos, M. Bagli, F. Jessen, T.A. Bayer, W. Maier, M.L. Rao, and R.A. Heun Genetic variation of the inflammatory cytokine IL-6 delays the initial onset, and reduces the risk for sporadic Alzheimer's disease Ann. Neurol. 45 1999 666 668
85. L.S. Perlmutter, E. Barron, and H.C. Chui Morphologic association between microglia and senile plaque amyloid in Alzheimer's disease Neurosci. Lett. 119 1990 32 36
86. B. Permanne, C. Adessi, G.P. Saborio, S. Fraga, M.J. Frossard, J. Van Dorpe, I. Dewachter, W.A. Banks, F. Van Leuven, and C. Soto Reduction of amyloid load and cerebral damage in a transgenic mouse model of Alzheimer's disease by treatment with a β-sheet breaker peptide FASEB J. 16 2002 860 862
87. R.T. Perry, J.S. Collins, H. Wiener, R. Acton, and R.C.P. Go The role of TNF and its receptors in Alzheimer's disease Neurobiol. Aging 22 2001 873 883
88. W.Q. Qiu, Z. Ye, D. Kholodenko, P. Seubert, and D.J. Selkoe Degradation of amyloid β-protein by a metalloprotease secreted by microglia and other neural and non-neural cells J. Biol. Chem. 272 1997 6641 6646
89. W.Q. Qiu, D.M. Walsh, Z. Ye, K. Vekrellis, J. Zhang, M.B. Podlisny, M.R. Rosner, A. Safavi, L.B. Hersh, and D.J. Selkoe Insulin-degrading enzyme regulates extracellular levels of amyloid β-protein by degradation J. Biol. Chem. 273 1998 32730 32738
90. J.B. Rich, D.X. Rasmusson, M.F. Folstein, K.A. Carson, C. Kawas, and J. Brandt Nonsteroidal anti-inflammatory drugs in Alzheimer's disease Neurology 45 1995 51 55
91. M. Ricote, J.T. Huang, J.S. Welch, and C.K. Glass The peroxisome proliferator-activated receptor(PPARγ) as a regulator of monocyte/macrophage function J. Leukoc. Biol. 66 1999 733 739
92. J. Rogers, L.C. Kirby, S.R. Hempelman, D.L. Berry, P.L. McGeer, A.W. Kaszniak, J. Zalinski, M. Cofield, L. Mansukhani, and P. Willson Clinical trial of indomethacin in Alzheimer' disease Neurology 43 1993 1609 1611
93. J.T. Rogers, L.M. Leiter, J. McPhee, C.M. Cahill, S.S. Zhan, and H. Potter Translation of the Alzheimer amyloid precursor protein mRNA is up-regulated by interleukin-1 through 5′-unstranslated region sequences J. Biol. Chem. 274 1999 6231 6421
94. S. Rossner, C. Lange-Dohna, U. Zeitschel, and J.R. Perez-Polo Alzheimer's disease β-secretase BACE1 is not a neuron-specific enzyme J. Neurochem. 92 2005 226 324
95. M. Sastre, I. Dewachter, G.E. Landreth, T.M. Willson, T. Klockgether, F. van Leuven, and M.T. Heneka Nonsteroidal anti-inflammatory drugs and peroxisome proliferator-activated receptor-γ agonists modulate immunostimulated processing of amyloid precursor protein through regulation of β-secretase J. Neurosci. 23 2003 9796 9804
96. M. Sastre, I. Dewachter, S. Roßner, N. Bogdanovic, E. Rosen, P. Borghgraef, B. Evert, L. Dumitrescu-Ozimek, D. Thal, G. Landreth, J. Walter, T. Klockgether, F. van Leuven, and M.T. Heneka NSAIDs repress BACE1 gene promoter activity by activation of the peroxisome proliferator-activated receptor-γ (PPARγ) Proc. Natl. Acad. Sci. U.S.A. 103 2006 443 448
97. S. Sauder, H. Kolsch, D. Lutjohann, A. Schulz, K. von Bergmann, W. Maier, and R. Heun Influence of peroxisome proliferator-activated receptor gamma gene polymorphism on 24S-hydroxycholesterol levels in Alzheimer's patients J. Neural Transm. 112 2005 1381 1389
98. D.J. Selkoe Folding proteins in fatal ways Nature 426 2003 900 904
99. D.J. Selkoe Defining molecular targets to prevent Alzheimer disease Arch Neurol. 62 2005 192 195
100. L.M. Sly, R.F. Krzesicki, J.R. Brashler, A.E. Buhl, D.D. McKinley, D.B. Carter, and J.E. Chin Endogenous brain cytokine mRNA and inflammatory responses to lipopolysaccharide are elevated in the Tg2576 transgenic mouse model of Alzheimer's disease Brain Res. Bull. 56 2001 581 588
101. W.F. Stewart, C. Kawas, M. Corrada, and E.J. Metter Risk of Alzheimer's disease and duration of NSAID use Neurology 48 1997 626 632
102. S. Sung, H. Yang, K. Uryu, E.B. Lee, L. Zhao, D. Shineman, J.Q. Trojanowski, V.M. Lee, and D. Pratico Modulation of nuclear factor-κ B activity by indomethacin influences Aβ levels but not Aβ precursor protein metabolism in a model of Alzheimer's disease Am. J. Pathol. 165 2004 2197 2206
103. C.A. Szekely, J.E. Thorne, P.P. Zandi, M. Ek, E. Messias, J.C. Breitner, and S.N. Goodman Nonsteroidal anti-inflammatory drugs for the prevention of Alzheimer's disease: a systematic review Neuroepidemiology 23 2004 159 169
104. Y. Takasashi, I. Hayashi, Y. Tominari, K. Rikimaru, Y. Morohashi, T. Kann, H. Natsugari, T. Fukuyama, T. Tomita, and T. Iwatsubo Sulindac sulfide is a non-competitive γ-secretase inhibitor that preferentially reduces Aβ42 generation J. Biol. Chem. 278 2003 18664 18670
105. E. Tamagno, P. Bardini, A. Obbili, A. Vitali, R. Borghi, D. Zaccheo, M.A. Pronzato, O. Danni, M.A. Smith, G. Perry, and M. Tabato Oxidative stress increases expression and activity of BACE in NT2 neurons Neurobiol. Dis. 10 2002 279 288
106. J. Tan, T. Town, and D. Paris Microglial activation resulting from CD40-CD40L interaction after β-amyloid Science 286 1999 2352 2355
107. T. Tanaka, H. Itoh, K. Doi, Y. Fukunaga, K. Hosoda, M. Shintani, J. Yamashita, T.H. Chun, M. Inoue, and K. Masatsugu Down regulation of peroxisome proliferator-activated receptorgamma expression by inflammatory cytokines and its reversal by thiazolidinediones Diabetologia 42 1999 702 710
108. T. Thomas, T.G. Nadackal, and K. Thomas Aspirin and non-steroidal anti-inflammatory drugs inhibit amyloid-beta aggregation Neuroreport 12 2001 3263 3267
109. P. Tontonoz, E. Hu, and B.M. Spiegelman Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor Cell 79 1994 1147 1156
110. J.D. Tugwood, I. Issemann, R.G. Anderson, K.R. Bundell, W.L. McPheat, and S. Green The mouse peroxisome proliferator activated receptor recognizes a response element in the 5′ flanking sequence of the rat acyl CoA oxidase gene EMBO J. 11 1992 433 439
111. D.M. Walsh, and D.J. Selkoe Deciphering the molecular basis of memory failure in Alzheimer's disease Neuron 44 2004 181 193
112. J. Walter, C. Kaether, H. Steiner, and C. Haass The cell biology of Alzheimer's disease: uncovering the secrets of secretases Curr. Opin. Neurobiol. 11 2001 585 590
113. S. Weggen, J.L. Eriksen, P. Das, S.A. Sagi, R. Wang, C.U. Pietrzik, K.A. Findlay, T.E. Smith, and M.P. Murphy A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity Nature 414 2001 212 216
114. S. Weggen, J.L. Eriksen, S.A. Sagi, C.U. Pietrzik, T.E. Golde, and E.H. Koo Aß42-lowering nonsteroidal anti-inflammatory drugs preserve intramembrane cleavage of the amyloid precursor protein and ErbB-4 receptor and signaling through the APP intracellular domain J. Biol. Chem. 278 2003 30748 30754
115. H.L. Weiner, and D.J. Selkoe Inflammation and therapeutic vaccination in CNS diseases Nature 420 2002 879 884
116. P.J. Whitehouse, D.L. Price, A.W. Clark, J.T. Coyle, and M.R. DeLong Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis Ann. Neurol. 10 1981 122 126
117. P.J. Whitehouse, D.L. Price, R.G. Struble, A.W. Clark, J.T. Coyle, and M.R. Delon Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain Science 215 1982 1237 1239
118. T.M. Willson, P.J. Brown, D.D. Sternbach, and B.R. Henke The PPARs: from orphan receptors to drug discovery J. Med. Chem. 43 2000 527 550
119. T. Wyss-Coray, J.D. Loike, T.C. Brionne, E. Lu, R. Anankov, F. Yan, S.C. Silverstein, and J. Husemann Adult mouse astrocytes degrade amyloid-beta in vitro and in situ Nat. Med. 9 2003 453 457
120. T. Wyss-Coray, J.D. Loike, T.C. Brionne, E. Lu, R. Anankov, F. Yan, S.C. Silverstein, and J. Husemann Adult mouse astrocytes degrade amyloid-β in vitro and in situ Nat. Med. 9 2003 453 457
121. H. Xing, J.P. Northrop, J.R. Grove, K.E. Kilpatric, J-L. Su, and G.M. Ringold TNF α-mediated inhibition and reversal of adipocyte differentiation is accompanied by suppressed expression of PPARγ without effects on Pref-1 expression Endocrinology 138 1997 2776 2783
122. Q. Yan, J. Zhang, H. Liu, S. Babu-Khan, R. Vassar, A.L. Biere, M. Citron, and G. Landreth Anti-inflammatory drug therapy alters beta-amyloid processing and deposition in an animal model of Alzheimer's disease J. Neurosci. 23 2003 7504 7509